3 Big Pharmas That Could be Winners for Investors in the Long Run Post author:Sam Post published:November 29, 2017 Post category:BioPharma Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace You Might Also Like Onxeo Plunges After Liver Cancer Drug Fails Late-Stage Study September 11, 2017 Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017 Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process October 5, 2017
Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017
Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process October 5, 2017
